Jeanne Clark
Jeanne Clark
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
TDPPR Group
New England Journal of Medicine. 346 (6), 393-403, 2002
206572002
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
Diabetes Prevention Program Research Group
The Lancet 374 (9702), 1677-1686, 2009
25222009
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...
New England Journal of Medicine 362 (18), 1675-1685, 2010
23602010
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
Look AHEAD Research Group
New England journal of medicine 369 (2), 145-154, 2013
19522013
The prevalence and etiology of elevated aminotransferase levels in the United States
JM Clark, FL Brancati, AM Diehl
The American journal of gastroenterology 98 (5), 960-967, 2003
15462003
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...
The Lancet 385 (9972), 956-965, 2015
13872015
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial
American Diabetes Association
Diabetes care 30 (6), 1374-1383, 2007
12052007
Nonalcoholic fatty liver disease
JM Clark, FL Brancati, AM Diehl
Gastroenterology 122 (6), 1649-1657, 2002
10882002
The epidemiology of nonalcoholic fatty liver disease in adults
JM Clark
Journal of clinical gastroenterology 40, S5-S10, 2006
9982006
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ...
Jama 305 (16), 1659-1668, 2011
8532011
The epidemiology of nonalcoholic fatty liver disease: a global perspective
M Lazo, JM Clark
Seminars in liver disease 28 (04), 339-350, 2008
8032008
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis
R Hernaez, M Lazo, S Bonekamp, I Kamel, FL Brancati, E Guallar, ...
Hepatology 54 (3), 1082-1090, 2011
7362011
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
EK Speliotes, LM Yerges-Armstrong, J Wu, R Hernaez, LJ Kim, ...
PLoS Genet 7 (3), e1001324, 2011
7152011
Comparative effectiveness of weight-loss interventions in clinical practice
LJ Appel, JM Clark, HC Yeh, NY Wang, JW Coughlin, G Daumit, ...
New England Journal of Medicine 365 (21), 1959-1968, 2011
6912011
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994
M Lazo, R Hernaez, MS Eberhardt, S Bonekamp, I Kamel, E Guallar, ...
American journal of epidemiology 178 (1), 38-45, 2013
6582013
The gene ontology (GO) project in 2006
Gene Ontology Consortium
Nucleic acids research 34 (suppl_1), D322-D326, 2006
6182006
Association of an intensive lifestyle intervention with remission of type 2 diabetes
EW Gregg, H Chen, LE Wagenknecht, JM Clark, LM Delahanty, J Bantle, ...
Jama 308 (23), 2489-2496, 2012
4982012
Serum ferritin and risk of the metabolic syndrome in US adults
M Jehn, JM Clark, E Guallar
Diabetes care 27 (10), 2422-2428, 2004
4912004
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis
JM Clark, AM Diehl
Jama 289 (22), 3000-3004, 2003
4892003
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
BA Neuschwander‐Tetri, JM Clark, NM Bass, ML Van Natta, ...
Hepatology 52 (3), 913-924, 2010
4352010
The system can't perform the operation now. Try again later.
Articles 1–20